Cornell researchers’ concept for a mobile phone-based system to detect infectious diseases and nutritional deficiencies in saliva was awarded a $100,000 NIH Technology Accelerator Challenge prize.
Researchers from Weill Cornell Medicine sampled gut bacteria from healthy fecal microbiota transplantation donors and from recipients with ulcerative colitis, identifying the bacterial strains that correlates with effective treatment.
For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.
Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.
Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.
On Aug. 16, the Class of 2026 received their short white coats during a Weill Cornell Medicine ceremony, officially marking the beginning of their medical educations.
Students living on campus have a new resource for support when they are experiencing distress, with the launch of the university’s Community Response Team at the start of this semester.